Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Kallikrein inhibitors and anti-thrombolytic agents and uses thereof

Kallikrein inhibitors and anti-thrombolytic agents and uses thereof

US Patent 8716225 · Granted May 6, 2014

Estimated economic value: $10,330,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Libraries of genetic packages comprising novel HC CDR3 designs2024
Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel2023
Display library process2022
Prevention and reduction of blood loss2022
Methods of constructing libraries comprising displayed and/or expressed members 2020
Libraries of genetic packages comprising novel HC CDR3 designs2020
Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel2020
Focused libraries of genetic packages2020
Display library process2020
Prevention and reduction of blood loss2019
Libraries of genetic packages comprising novel HC CDR3 designs2018
Peptides that specifically bind HGF receptor (cMet) and uses thereof2017